Sameer J Khandhar MD
Interventional Cardiology
HISNJ Endowed Chief of Cardiology at Penn Presbyterian Medical Center Associate Professor of Clinical Medicine, University of Pennsylvania
Join to View Full Profile
51 N 39th StHeart and Vascular Pavilion 4th FloorPhiladelphia, PA 19104
Phone+1 215-662-9000
Fax+1 215-662-9733
Dr. Khandhar is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sameer Khandhar, based in Philadelphia, PA, is a cardiologist specializing in interventional cardiology. He is the current Chief of Cardiology at the University of Pennsylvania Presbyterian Medical Center.
He completed his medical education at Northeast Ohio Medical University in 2003, followed by a residency in Internal Medicine at the University of Pennsylvania Health System and fellowships in Cardiovascular Disease and Interventional Cardiology at UPMC. His experience focuses on interventional cardiology, pulmonary embolism, and cardiac critical care.
Dr. Khandhar has contributed to the field through multiple publications on catheter-directed thrombolysis and pulmonary embolism large bore thrombectimy. , with some studies receiving citations.
Education & Training
UPMC Medical EducationFellowship, Interventional Cardiology, 2009 - 2011- UPMC Medical EducationFellowship, Cardiovascular Disease, 2006 - 2009
University of Pennsylvania Health SystemResidency, Internal Medicine, 2003 - 2006
Northeast Ohio Medical UniversityClass of 2003
Certifications & Licensure
NJ State Medical License 2014 - 2027
PA State Medical License 2003 - 2026
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification dbMotion, dbMotion Inc., 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
- Endothelial Injury and Development of Coronary Intimal Thickening After Heart Transplantation Start of enrollment: 2012 Sep 01
Publications & Presentations
PubMed
- 2 citationsEvaluation of Catheter-Directed Thrombolysis Device Type and Dosing on Treatment Outcomes in Intermediate-Risk Pulmonary Embolism: A PEERLESS Randomized Controlled Tri...Carin F Gonsalves, Stefan Stortecky, Samuel Horr, Orestis Pappas, Ripal T Gandhi
Journal of Vascular and Interventional Radiology. 2026-01-01 - 88 citationsLarge-Bore Mechanical Thrombectomy Versus Catheter-Directed Thrombolysis in the Management of Intermediate-Risk Pulmonary Embolism: Primary Results of the PEERLESS Ran...Wissam A Jaber, Carin F Gonsalves, Stefan Stortecky, Samuel Horr, Orestis Pappas
Circulation. 2025-02-04 - 1 citationsEconomic Analysis of Catheter-Directed Thrombolysis for Intermediate-Risk Pulmonary Embolism.Elina Pliakos, Lauren Glassmoyer, Taisei Kobayashi, Steven Pugliese, Hari Shankar
Catheterization and Cardiovascular Interventions. 2025-02-01
Press Mentions
A Runner’s Rapid SaveOctober 10th, 2025- FLASH: PE Patients Show Ongoing Clinical, QoL Gains with ThrombectomyMay 21st, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
